These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35457449)

  • 21. Operational research within the national tuberculosis control programme in Benin.
    Ade S; Affolabi D; Adjobimey M; Ade G; Anagonou S; Kumar AMV; Harries AD
    BMC Res Notes; 2017 Nov; 10(1):651. PubMed ID: 29187248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research, Innovation, and Policy: An Alliance Combating Antimicrobial Resistance.
    van Hengel AJ; Marin L
    Trends Microbiol; 2019 Apr; 27(4):287-289. PubMed ID: 30638776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?
    Dondorp AM; Limmathurotsakul D; Ashley EA
    Intensive Care Med; 2018 Jan; 44(1):79-82. PubMed ID: 28409205
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial Resistance in Low- and Middle-income Countries.
    Chopra S; Rizvi M
    Clin Infect Dis; 2019 Sep; 69(7):1264-1265. PubMed ID: 30753365
    [No Abstract]   [Full Text] [Related]  

  • 26. Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.
    Samuel F Orubu E; Sutradhar I; Zaman MH; Wirtz VJ
    J Glob Health; 2020 Dec; 10(2):020414. PubMed ID: 33110576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global analysis of strategies to tackle antimicrobial resistance.
    Adeniji F
    Int J Pharm Pract; 2018 Feb; 26(1):85-89. PubMed ID: 28544416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.
    Boyer S; Koulla-Shiro S; Abé C; Spire B; Moatti JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):239-44. PubMed ID: 21537170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance: A global emerging threat to public health systems.
    Ferri M; Ranucci E; Romagnoli P; Giaccone V
    Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2857-2876. PubMed ID: 26464037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility.
    Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S
    J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The public health problem of OTC antibiotics in developing nations.
    Khalid L; Mahsood N; Ali I
    Res Social Adm Pharm; 2016; 12(5):801-2. PubMed ID: 27067233
    [No Abstract]   [Full Text] [Related]  

  • 32. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E
    Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need for building design professionals in operational research in low-income countries.
    Taub M
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):565; author reply 565-6. PubMed ID: 22640516
    [No Abstract]   [Full Text] [Related]  

  • 35. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
    Mahadi AR
    Front Public Health; 2021; 9():770593. PubMed ID: 34976929
    [No Abstract]   [Full Text] [Related]  

  • 36. Tracking the career development of scientists in low- and middle-income countries trained through TDR's research capacity strengthening programmes: Learning from monitoring and impact evaluation.
    Halpaap B; Vahedi M; Certain E; Alvarado T; Saint Martin C; Merle C; Mihut M; Launois P
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006112. PubMed ID: 29216192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The published research paper: is it an important indicator of successful operational research at programme level?
    Zachariah R; Tayler-Smith K; Ngamvithayapong-Yana J; Ota M; Murakami K; Ohkado A; Yamada N; Van Den Boogard W; Draguez B; Ishikawa N; Harries AD
    Trop Med Int Health; 2010 Nov; 15(11):1274-7. PubMed ID: 20976874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meeting global health challenges through operational research and management science.
    Royston G
    Bull World Health Organ; 2011 Sep; 89(9):683-8. PubMed ID: 21897489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EC launches action plan to tackle antimicrobial resistance.
    Vet Rec; 2011 Nov; 169(22):565-6. PubMed ID: 22121172
    [No Abstract]   [Full Text] [Related]  

  • 40. Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    Gingaras C; Collins E
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38622730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.